The force behind the multimillion-dollar effort against banning surprise medical bills is not only medical professionals, but also private equity and venture capital firms.
As proposals to ban surprise medical bills move through Congress and state legislatures with rare bipartisan support, physician groups have emerged as the loudest opponents.
Often led by doctors with the veneer of noble concern for patients, physician-staffing firms — third-party companies that employ doctors and assign them out to health care facilities — have opposed efforts to limit the practice known as balance billing. They claim such bans would rob doctors of their leverage in negotiating, drive down their payments and push them out of insurance networks.
Opponents have been waging well-financed campaigns. Slick TV ads and congressional lobbyists seek to stop legislation that had widespread support from voters. Nearly 40% of patients said they were "very worried" about surprise medical bills, which generally arise when an insured individual inadvertently receives care from an out-of-network provider.
But as lobbyists purporting to represent doctors and hospitals fight the proposals, it has become increasingly clear that the force behind the multimillion-dollar crusade is not only medical professionals, but also investors in private equity and venture capital firms.
In the past eight years, in such fields as emergency medicine and anesthesia, investors have bought and now operate many large physician-staffing companies. And key to their highly profitable business strategy is to not participate in insurance networks, allowing them to send surprise bills and charge patients a price they set — with few limitations.
"We've started to realize it's not us versus the hospitals or the doctors, it's us versus the hedge funds," said James Gelfand, senior vice president of health policy at ERIC, a group that represents large employers.
"They have money to burn," said a Democratic congressional aide with knowledge of the lobbying efforts "They're in take-the-bill-down mode."
Private equity firms and the staffing companies they own have a lot to lose, too. While doctors largely once worked for hospitals or had individual contracts, many hospitals now rely on these huge staffing businesses to provide doctors for various departments. Companies like Envision Physician Services and TeamHealth provide doctors to dozens, sometimes hundreds of hospitals. Private equity firms back these ever-growing outsourced staffing companies.
Because patients have no effective way to protect themselves from unexpected medical bills, even knowledgeable, proactive people with comprehensive insurance can find themselves whisked away to an out-of-network hospital in an emergency or treated by an out-of-network anesthesiologist at the in-network hospital they selected.
Several lawmakers have adopted the issue, one seemingly ready-made for campaign season: In fighting surprise bills, they are attacking a practice both reviled by the public and easy to explain.
What's harder to explain is where the money on the other side of the campaign comes from. Coalitions like Physicians for Fair Coverage and dark-money groups with innocuous names like Doctor Patient Unity have flooded the airwaves with ads urging people to call their lawmakers and voice opposition to ending surprise bills. And those lawmakers are overwhelmingly senators facing difficult reelection fights next year, who might be hesitant to vote for change — especially if it means more expensive ad campaigns aimed at taking them down.
To understand the power and size of private equity in the U.S. health care system, one must first understand physician-staffing firms.
Increasingly, hospitals have turned to third-party companies to fill their facilities with doctors. Among driving factors: physician shortages, a bigger insured population because of the Affordable Care Act and an aging population, according to research from the investment firm Harris Williams & Co.
In some areas, doctors have few options but to contract with a staffing service, which hires them out and helps with the billing and other administrative headaches that occupy much of a doctor's time. Staffing companies often have profit-sharing agreements with hospitals, so some of the money from billing patients is passed back to the hospitals.
The two largest staffing firms, EmCare and TeamHealth, together make up about 30% of the physician-staffing market.
That's where private equity comes in. A private equity firm buys companies and passes on the profits they squeeze out of them to the firm's investors. Private equity deals in health care have doubled in the past 10 years. TeamHealth is owned by Blackstone, a private equity firm. Envision and EmCare are owned by KKR, another private equity firm.
With affiliates in every state, these privately owned, profit-driven companies staff emergency rooms, own dialysis facilities and operate physician practices. Research from 2017 shows that when EmCare entered a market, out-of-network billing rates went up between 81 and 90 percentage points. When TeamHealth began working with a hospital, its rates increased by 33 percentage points.
A study by the Kaiser Family Foundation found that 1 in 6 Americans with insurance were surprised by a medical bill after treatment at a hospital in 2017.
That is no coincidence: In many states, balance billing — when a provider charges a patient the difference between their fee and what their insurance company paid — is legal, so physician-staffing services have little incentive to contract with insurance companies and provide in-network doctors.
"These physician-staffing companies are benefiting tremendously from the ability to bill out-of-network," said Zack Cooper, an associate professor of public health at Yale, who has studied physician-staffing firms and balance billing. "It's a small but profitable sliver of the health care system that these firms are using to make pretty significant amounts of money."
Cooper said the business models are built on the ability to get profits from balance billing.
"Private equity firms are buying up physician practices that allow them to bill out-of-network, cloaking themselves in the halo that physicians generally receive and then actively watering down any legislation that would both protect patients but affect their bottom line," Cooper said.
The staffing firm Envision disputed this assessment of its business model. An emailed statement said more than 90% of its business comes from in-network agreements and that the company continues "actively advocating for a federal solution to surprise medical bills."
The two possible solutions on the table in congressional legislation are arbitration and benchmarking.
Arbitration sends the insurers and health care providers through an independent review to determine a fair price in the event of a balance bill.
Under benchmarking, out-of-network physician charges are paid by the patient's health plan based on an average of what other in-network doctors in the area are paid. Money is being spent on all sides of the debate, but for the physicians and private equity firms, it's weighted most heavily on the side of arbitration.
Assorted groups have organized themselves into different coalitions and mega-groups to pool resources for lobbying and ads. On the side of benchmarking, there is the Coalition Against Surprise Medical Billing, made up of employers and insurers like Blue Cross Blue Shield, the Association of Health Insurance Plans and ERIC, which represents large employers.
On the arbitration side, there is Out of the Middle, Physicians for Fair Coverage, SOAR and Doctor Patient Unity, to name a few. Ostensibly, these are composed of doctor and hospital groups.
"It's important that federal legislation to end surprise billing also incentivizes all providers and insurers to negotiate in good faith in order to increase the number of in-network providers and ensure patients' continued access to high-quality medical care," added Megan Taylor, a spokeswoman for Physicians for Fair Coverage.
Yet these groups are dominated by private equity and hedge-fund-backed organizations. Physicians for Fair Coverage is made up of ApolloMD (a staffing firm owned in part by the investment firm ValorBridge), Radiology Partners (a staffing firm owned in part by the investment firm New Enterprise Associates) and a trio of staffing firms called US Acute Care Solutions, US Radiology Specialists and US Anesthesia partners (all partly owned by the investment firm Welsh, Carson, Anderson and Stowe).
Among the groups listed as lobbying on surprise bills are hospital groups like Christus Health (which usesEmCare) and Wellstar Health Systems (which uses ApolloMD). In addition, HCA, a large hospital chain that has had a joint venture with EmCare, has also been active on these issues.
Even the groups that appear to represent independent doctors are tied to private equity and staffing firms. Out of the Middle consists of trade organizations for specialty doctors, like the American College of Emergency Physicians (ACEP) and the American Society of Anesthesiologists and many others. It's mostly run by ACEP, whose immediate past president, Dr. Rebecca Parker, was also a senior vice president at Envision.
Spending on lobbying around this issue has been generous, according to disclosures from the Center for Responsive Politics. The staffing firm Mednax spent $180,000 on lobbying the House and Senate. TeamHealth and TeamHealth Inc. together spent $100,000. Physicians for Fair Coverage spent $145,000. US Physician Partners, an "informal lobbying group" that never lobbied before 2019, spent $130,000.
"There's no way we can match them," said Gelfand, from ERIC. "We're entering this debate knowing we're being horrifically outspent."
Over six years, the state institution filed 36,000 lawsuits against patients seeking a total of more than $106 million in unpaid bills, a KHN analysis finds.
This article was first published on Tuesday, September 10, 2019 in Kaiser Health News.
Heather Waldron and John Hawley are losing their four-bedroom house in the hills above Blacksburg, Va. A teenage daughter, one of their five children, sold her clothes for spending money. They worried about paying the electric bill. Financial disaster, they say, contributed to their divorce, finalized in April.
Their money problems began when the University of Virginia Health System pursued the couple with a lawsuit and a lien on their home to recoup $164,000 in charges for Waldron's emergency surgery in 2017.
The family has lots of company: Over six years ending in June 2018, the health system and its doctors filed 36,000 lawsuits against patients seeking a total of more than $106 million, seizing wages and bank accounts, putting liens on property and homes and forcing families into bankruptcy, a Kaiser Health News analysis has found.
Unpaid hospital bills are a leading cause of personal debt and bankruptcy across the nation, with hospitals from Memphis to Baltimorecriticized for their role in pushing families over the financial edge. But UVA stands out for the scope of its collection efforts and how persistently it seeks payment, pursuing poor as well as middle-class patients for almost all they're worth.
KHN's findings, based on court records, documents and interviews with hospital officials and dozens of patients, show UVA:
Sued patients for as much as $1 million and as little as $13.91, and garnished thousands of paychecks, largely from workers at lower-pay employers such as Walmart, where UVA took wages more than 800 times.
Seized $22 million over six years in state tax refunds owed to patients with outstanding bills, most of it without court judgments, under a program intended to help state and local governments collect debts.
Sued about 100 patients every year who also happened to be UVA Health System employees and filed thousands of property liens over the years, from Albemarle County all the way to Georgia.
Dunned some former patients an additional 15% for legal costs, plus 6% interest on their unpaid bills, which over years can add up to more than the original bill.
Has the most restrictive eligibility guidelines for patient financial assistance of any major hospital system in Virginia. Savings of only $4,000 in a retirement account can disqualify a family from aid, even if its income is barely above the poverty level.
The hospital ranked No. 1 in Virginia by U.S. News & World Report is taxpayer-supported and state-funded, not a company with profit motives and shareholder demands. Like other nonprofit hospitals, it pays no federal, state or local taxes on the presumption it offers charity care and other community benefits worth at least as much as those breaks. Democratic Gov. Ralph Northam, a pediatric neurologist, oversees its board.
UVA defended the institution's practices as legally required and necessary "to generate positive operating income" to invest in medical education, new facilities, research and the latest technology. They point to the Virginia Debt Collection Act of 1988, which requires state agencies to "aggressively collect" money owed.
"Sending unpaid bills to a collection agency or pursuing a civil claim is a last resort," said UVA Health System spokesman Eric Swensen. Two years ago, he said, the health system limited lawsuits to cases in which patients owe more than $1,000. "For the vast majority of patients, we are able to agree upon workable payment plans without filing a legal claim," he said.
In addition, UVA is "making a comprehensive review" of its charity care rules and "considering policies to provide additional financial assistance to low-income patients not covered by our existing charity care policies," he said.
Swensen declined to discuss individual cases, saying the hospital was bound by patient confidentiality. UVA Health CEO Pamela Sutton-Wallace declined an interview request. A spokeswoman for Northam did not respond to repeated requests for comment.
Though there is no national data on hospital debt collection, UVA's pursuit of patients goes beyond that of a number of institutions. Johns Hopkins Hospital in Baltimore has sued patients 240 times a year on average, according to a May report in The Baltimore Sun. UVA, by comparison, often sues that many former patients in a week and averages more than 6,000 cases annually, court data show.
Private, nonprofit Yale New Haven Health System files liens only if a bill is over $10,000 and then only if the property is worth at least $300,000, a spokesman said. Falls Church, Va.-based Inova Health says it does not file liens on patient homes or garnish wages.
Industry standards are few and vague. The American Hospital Association says its members follow Internal Revenue Service guidelines, which merely require hospitals to have a financial assistance policy and to make "reasonable efforts" to determine whether a patient qualifies for help before initiating collections.
Patients find themselves unable to pay UVA bills for many reasons: They are uninsured or sometimes have short-term coverage that does not pay for treatment of preexisting illnesses. Or they are out-of-network, or have a "high-deductible" plan — increasingly common coverage that can require patients to pay more than $6,000 before insurance kicks in. Virginia's Medicaid expansion, effective this year, covers families with low income but is still projected to leave hundreds of thousands uninsured.
Patients also have trouble because, like many U.S. hospitals, UVA bills people lacking coverage at rates far higher than what insurance companies pay on behalf of members. In addition, experts say such bills often have little connection to the cost of care. Insurers obtain huge discounts off hospital sticker prices — 70% on average in UVA's case, according to documents it files with Medicare.
UVA offers uninsured patients 20% off to start and an additional 15% to 20% if they pay promptly, Swensen said. Few are able to do that. Patients are subject to collections and lawsuits if they do not pay or arrange to do so within four months, he said.
The $164,000 billed to Heather Waldron for intestinal surgery was more than twice what a commercial insurer would have paid for her care, according to benefits firm WellRithms, which analyzed bills for Kaiser Health News using cost reports UVA files with the government. Charges on her bill included $2,000 for a $20 feeding tube.
UVA would not disclose basic information about patient lawsuits, liens and garnishments. Reporters reconstructed the hospital's practices by talking directly with patients, analyzing court documents and hospital bills and observing the legal process in court. They gathered records in Charlottesville, where the UVA Health System is located, to supplement a courts database compiled by the nonprofit Code for Hampton Roads, which works to improve government technology.
The picture that emerges is of a trusted institution whose practices violate its stated public mission, with little accountability or redress for its patients.
Waldron, 38, an insurance agent and former nurse, appreciates the treatment she received for an intestinal malformation that almost killed her. But, she said, "UVA has ruined us."
'Here For A Hospital Case?'
UVA sues so many patients that District Court Judge William Barkley doesn't announce the cases as he takes the bench each Thursday in the historic brick courthouse in Charlottesville. On this day, he waves a thick stack of litigation at defendants, asking, "Is anybody here for a hospital case?" Nobody needs to ask which hospital.
A recent NPR report noted that nonprofit Mary Washington Healthcare, in Fredericksburg, Va., had 300 cases in court in one month. (Following that report the hospital announced that it would suspend the practice of suing patients for unpaid bills.)
Barkley's court often handles 300 UVA suits in a week, data shows.
The court often operates like a UVA billing office. UVA sends collections representatives, not lawyers, who sit near the judge's bench. They give patients two weeks to commit to an interest-free payment plan, according to courtroom meetings witnessed by a reporter. Otherwise, "we're already going to be reviewing it for garnishment," a UVA official tells a car accident victim. With bills often in the tens of thousands of dollars, even the five-year, interest-free plans are unaffordable, patients said.
Swensen said patients in court would have already received "four to five" bills over several months and notifications about potential financial assistance.
Zann Nelson — who is 70, lives in Reva, Va., and was sued by UVA for $23,849 a few years ago — is a rare patient who fought back. Admitted with a newly diagnosed uterine cancer, she was bleeding and in pain when she signed an open-ended payment agreement. In court, she argued it was so vague as to be unenforceable. (C-Ville Weekly, a local paper, wrote about her case in 2014.)
She lost. The judge, according to court records, said that Nelson had "the ability to decline the surgery" if she didn't like the terms of the deal. She lived with a lien on her farm until she managed to pay off the debt.
'Can't Afford To Go Back'
>
UVA Medical Center, the flagship of UVA Health System, earned $554 million in profit over the six years ending in June 2018 and holds stocks, bonds and other investments worth $1 billion, according to financial statements. CEO Sutton-Wallace earns a salary of $750,000, with bonus incentives that could push her annual pay close to $1 million, according to a copy of her employment contract, obtained under public information law.
Yet UVA offers financial assistance that's more limited than any other major health system in Virginia, according to an analysis of policies at organizations including Inova, Sentara Healthcare, Riverside Health and Carilion Clinic.
To qualify for help, UVA patients must earn less than 200% of federal poverty guidelines ($34,000 for a couple) and own less than about $3,000 in assets, not counting a house, according to the hospital's website and guidelines UVA files with the state.
Carilion Clinic, by contrast, provides aid to families with income up to 400% of poverty guidelines and assets of less than $100,000, other than a house. If bills at Riverside Health exceed household income over 12 months, the hospital forgives the whole amount.
Sentara slashed lawsuit volume by using software to rule out patients who were unlikely to pay, said spokesman Dale Gauding. "We write off a lot of bad debt rather than put someone through a judgment they can't pay and an additional black mark on their credit," he said.
The only other policy in Virginia similar to UVA's is that of VCU Health, a sister state hospital system with the same income and asset guidelines. In July, VCU started offering help to some patients with "catastrophic" and "prohibitively expensive" bills who don't otherwise qualify, a spokesman said.
"We are considering those updates," Swensen said of VCU's changes. He noted that for the most recent fiscal year UVA approved almost 10,000 applications for charity care. Most of the patients who qualify pay nothing beyond a $6 copay, he said.
UVA sued Carolyn Davis, 55, of Halifax County, for $7,448 to pay for nerve injections to treat back pain that she hadn't realized would be out-of-network.
Her husband is a cook at Hardee's, taking home $500 to $600 a week, she said. UVA refused their application for financial assistance because his Hardee's 401(k) balance of $6,000 makes them too well-off, she said.
"We don't have that kind of money," Davis said. The hospital insisted on a monthly payment of $75. She was meeting it by charging it to her credit card at 22% interest.
Charges for Davis' treatment were about twice what a commercial insurer would have paid, according to an estimate by WellRithms.
Sometimes patients who are prepared to pay cash for UVA treatment find they can't afford the charges. Wayne Williams, 43, of Charlottesville, is a custodian at a community college. He was uninsured but feared he had strep throat last year.
"I thought they were going to give me some antibiotics," he said.
Instead, UVA's emergency department gave him a CT scan, a bill for $6,931 and, when he didn't pay, a lawsuit. UVA did give him a 30% discount based on his financial circumstances, he said — meaning the sore throat would cost about $4,800.
WellRithms calculated that a commercial insurance company would have paid $992 for the care Williams received, which would have covered costs and generated a profit.
Leigh Ann Beach, 37, of Palmyra, experienced how differently hospitals treat those who cannot pay after hurting her ankle in a bike accident.
Rising premiums left her uninsured when she fell off a bike and hurt her ankle last year. Her husband works in construction to provide for their family with seven children. A rainy 2018 washed out working days and his income. They couldn't afford their $667 monthly insurance premium.
Sentara Martha Jefferson Hospital, which first treated her, canceled the entire $4,650 bill in light of her family's income, her paperwork shows. UVA, where she got surgery and metal implants, sued her for $9,505 and rejected her request for financial help.
A UVA representative said she could sell some acreage from her small rural home to pay the bill, she said. She limps and is in pain, but "I can't afford to go back," she said.
Resorting To Bankruptcy
>
When Jesse Lynn, 42, of Orange County, bought short-term coverage as a bridge between policies, he and wife Renee didn't realize the plan considered Jesse's old back problems a preexisting illness, and therefore would not pay for treatment.
After back surgery at Culpeper Medical Center, a UVA affiliate, he came out with a bill for about $230,000, Renee Lynn said.
The surgeon reduced his portion of the charges — from $32,000 to $4,500, which they thought was reasonable. They asked for a similar break or a payment delay from UVA. "We are not a lending institution," the billing office told her, she said.
The Lynns decided bankruptcy was their only option.
"I probably see at least a couple a month," said Marshall Slayton, a Charlottesville bankruptcy lawyer, holding up a new file. "This is the third case this week."
UVA said it doesn't foreclose on primary residences. But often a UVA lawsuit leads to home loss because patients' credit is downgraded and they cannot keep up with hospital payment plans and mortgages.
Property liens do give UVA a claim on the equity in patients' homes.
"We see a lot of them," said Tina Merritt, a partner with True North Title in Blacksburg. "And a lot of people don't even know until they go to sell the property."
It took Priti Chati, 62, of Roanoke six years to pay a $44,000 UVA bill for brain surgery and have a home lien removed last year, court records show. She had had a pre-Obamacare policy that did not cover preexisting illness. The health system seized bank funds intended for her daughters' college costs, she said. She sold jewelry and borrowed from friends, eventually paying more than $70,000 including interest, she said.
Paul Baker, 41, of Madison County ran a small lawn service and with his wife owes more than $500,000 for treatment after their truck rolled over. He is grateful to UVA "for saving my life," he said. But he is "frustrated they are ultimately taking my farm" when he sells or dies, a result of UVA's lawsuit.
Indigent Care
Swensen said the medical center gave $322 million in financial assistance and charity care in fiscal 2018. But legal and finance experts said that's not a reliable estimate.
The $322 million "merely indicates the amount they would have charged arbitrarily" before negotiated insurer discounts, said Ge Bai, an accounting and health policy associate professor at the Johns Hopkins Carey Business School.
The figure is "based on customary reporting standards used by hospitals across the U.S.," Swensen said.
Insurers would have paid UVA only $88 million for that care, according to an accounting of unpaid bills presented in September 2018 to the UVA Health board. Even that unpaid figure did not come out of UVA's purse since federal and state governments provided "funding earmarked to cover indigent care" for almost all of it — $83.7 million, according to Bai.
The real, "unfunded" cost of UVA indigent care: $4.3 million, or 1.3% of what it claims, according to the document.
"That's nothing," given how much money UVA makes, Bai said. "Nonprofit hospitals advance their charitable mission primarily through providing indigent care."
The hospital recorded an additional $109 million in uncollectible debts not considered indigent care, the document shows.
Nacy Sexton, who is in his 30s and lives outside Richmond, hoped he might get a break on his medical bills as a student enrolled at Virginia. He was close to graduation in 2015 when he was hospitalized for lupus. After he was unable to cover the reduced bill offered by the hospital, the university blocked his enrollment, a notice he received from student financial services shows.
"The university places enrollment holds on student accounts for many reasons, including unpaid tuition and medical bills," said university spokesman Wesley Hester. This semester the university has "active holds" on 20 students because of unpaid medical center bills, which might or might not block their attendance depending on when the hold was placed, he said.
Sexton still has about $4,000 to go on a bill that he said was more than $30,000 before UVA's discount, a fundraising campaign and other payments. He hopes to re-enroll and finish his degree in education next year.
"When you get sick, why should it affect your education?" he asked.
Shirley Perry was a registered nurse at the medical center who was "so proud of working at UVA," said her mother, Vera Perry. She became chronically ill, lost her job and insurance, and then needed treatment from her former employer. UVA sued her for $218,730 plus $32,809 in legal fees. She died last year at age 51, with a UVA lien on her townhouse. It was auctioned off on Aug. 7 at the Albemarle County Courthouse.
For Heather Waldron, the path from "having everything and being able to buy things and feeling pretty good" to "devastation" began when she learned after her UVA hospitalization that a computer error involving a policy bought on healthcare.gov had led to a lapse in her insurance.
She is now on food stamps and talking to bankruptcy lawyers. A bank began foreclosure proceedings in August on the Blacksburg house she shared with her family. The home will be sold to pay off the mortgage.
She expects UVA to take whatever is left.
Methodology
KHN analyzed Virginia civil case records from both the district and circuit courts from July 2012 through June 2018, based on the date a case was filed. These case records were acquired from Ben Schoenfeld, a volunteer for Code for America, a nonprofit focused on improving government technology. Schoenfeld compiles court records that are available directly from Virginia's court system (from bothcircuit anddistrict courts) and posts them on the website VirginiaCourtData.org.
The Circuit Courts of Alexandria and Fairfax do not use the statewide case management system and are not included in this analysis.
The online circuit court cases do not include the amount for which the plaintiff sued. KHN went to the Albemarle Circuit Court (where most of the UVA circuit cases were filed) and looked up each of over 900 cases by hand to obtain the dollar amount, which totaled over $60 million.
The online district court cases do include a principal amount sought in a "Warrant in Debt" case. However, if the case is settled or dismissed, the principal amount is zero. Therefore, KHN's reporting of the total for which UVA has sued its patients during this period is likely a low estimate.
KHN focused on district cases that were "Warrant in Debt" cases and circuit cases that were "Complaint — Catch-all" or "Contract Action." UVA sues to recover patient debt from all three categories. For cases brought by the University of Virginia, the plaintiff names (as entered by the court) vary widely: "University of Virginia," "Rectors and Visitors of UVA" or just "UVA" are some examples. We included cases that mentioned the UVA Physicians Group and Health Services Foundation (although these were much less prevalent). In some cases, the UVA Medical Center was named specifically; in others, it was not. KHN analyzed cases brought by the university whether or not the case specifically mentioned the medical center, knowing that some cases omit this detail. We took a random sample of 30 "Warrant in Debt" cases from the Albemarle District Court in 2017 that were filed by "Rectors and Visitors" but did not specify the medical center. We looked up the original records at the courthouse; each one was related to the medical center.
KHN also found several 2012 cases filed in the Albemarle Circuit Court by UVA that were not in the public data available online, which suggests that the data is not necessarily complete.
KHN contacted UVA directly on multiple occasions. We filed several public records requests for the number of cases involving medical debt and the total amount sought, as well as the total amount recovered. Each time our request was denied.
SAN FRANCISCO — Economists and researchers long have blamed the high cost of health care in Northern California on the giant medical systems that have gobbled up hospitals and physician practices — most notably Sutter Health, a nonprofit chain with 24 hospitals, 34 surgery centers and 5,000 physicians across the region.
Now, those arguments will have their day in court: A long-awaited class-action lawsuit against Sutter is set to open Sept. 23 in San Francisco Superior Court.
The hospital giant, with $13 billion in operating revenue in 2018, stands accused of violating California's antitrust laws by leveraging its market power to drive out competition and overcharge patients. Health care costs in Northern California, where Sutter is dominant, are 20% to 30% higher than in Southern California, even after adjusting for cost of living, according to a 2018 study from the Nicholas C. Petris Center at the University of California-Berkeley cited in the complaint.
The case was initiated in 2014 by self-funded employers and union trusts that pay for worker health care. It since has been joined with a similar case brought last year by California Attorney General Xavier Becerra. The plaintiffs seek up to $900 million in damages for overpayments that they attribute to Sutter; under California's antitrust law, the award can be tripled, leaving Sutter liable for up to $2.7 billion.
The case is being followed closely by industry leaders and academics alike.
"This case could be huge. It could be existential," said Glenn Melnick, a health care economist at the University of Southern California. If the case is successful, he predicted, health care prices could drop significantly in Northern California. It also could have a "chilling effect" nationally for large health systems that have adopted similar negotiating tactics, he said.
The case already has proved controversial: In November 2017, San Francisco County Superior Court Judge Curtis E.A. Karnow sanctioned Sutter after finding it had intentionally destroyed 192 boxes of documents sought by plaintiffs, "knowing that the evidence was relevant to antitrust issues." He wrote: "There is no good explanation for the specific and unusual destruction here."
Antitrust enforcement is more commonly within the purview of the Federal Trade Commission and U.S. Department of Justice. "One of the reasons we have such a big problem [with consolidation] is that they've done very little. Enforcement has been very weak," said Richard Scheffler, director of the Nicholas C. Petris Center. From 2010 to 2017, there were more than 800 hospital mergers, and the federal government has challenged just a handful.
"We feel very confident," said Richard Grossman, lead counsel for the plaintiffs. "Sutter has been able to elevate their prices above market to the tune of many hundreds of millions of dollars."
Or, as Attorney General Becerra put it at a news conference unveiling his 2018 lawsuit: "This is a big 'F' deal."
Sutter vigorously denies the allegations, saying its large, integrated health system offers tangible benefits for patients, including more consistent high-quality care. Sutter also disputes that its prices are higher than other major health care providers in California, saying its internal analyses tell a different story.
"This lawsuit irresponsibly targets Sutter's integrated system of hospitals, clinics, urgent care centers and affiliated doctors serving millions of patients throughout Northern California," spokeswoman Amy Thoma Tan wrote in an emailed statement. "While insurance companies want to sell narrow networks to employers, integrated networks like Sutter's benefit patient care and experience, which leads to greater patient choice and reduces surprise out-of-network bills to our patients."
There's no dispute that for years Sutter has worked aggressively to buy up hospitals and doctor practices in communities throughout Northern California. At issue in the case is how it has used that market dominance.
According to the lawsuit, Sutter has exploited its market power by using an "all-or-none" approach to contracting with insurance companies. The tactic — known as the "Sutter Model" — involves sitting down at the negotiating table with a demand: If an insurer wants to include any one of the Sutter hospitals or clinics in its network, it must include all of them. In Sutter's case, several of its 24 hospitals are "must-haves," meaning it would be almost impossible for an insurer to sell an insurance plan in a given community without including those facilities in the network.
"All-or-none" contracting allows hospital systems to demand higher prices from an insurer with little choice but to acquiesce, even if it might be cheaper to exclude some of the system's hospitals that are more expensive than a competitor's. Those higher prices trickle down to consumers in the form of higher premiums.
The California Hospital Association contends such negotiations are crucial for hospitals struggling financially. "It can be a great benefit to small hospitals and rural hospitals that don't have a lot of bargaining power to have a larger group that can negotiate on their behalf," said Jackie Garman, the CHA's legal counsel.
Sutter also is accused of preventing insurers and employers from tiering benefits, a technique used to steer patients to more cost-effective options. For example, an insurer might charge $100 out-of-pocket for a procedure at a preferred surgery center, but $200 at a more expensive facility. In addition, the lawsuit alleges that for years Sutter restricted insurers from sharing information about its prices with employers and workers, making it nearly impossible to compare prices when selecting a provider.
Altogether, the plaintiffs allege, such tactics are anti-competitive and have allowed Sutter to drive up the cost of care in Northern California.
Hospitals in California and other regions across the country have watched the success of such tactics and taken note. "All the other hospitals want to emulate [Sutter] to get those rates," said Anthony Wright, executive director of the advocacy group Health Access.
A verdict that finds such tactics illegal would "send a signal to the market that the way to compete is not to be the next Sutter," said Wright. "You want them to compete instead by providing better quality service at a lower price, not just by who can get bigger and thus leverage a higher price."
Along with damages, Becerra's complaint calls for dismantling the Sutter Model. It asks that Sutter be required to negotiate prices separately for each of its hospitals — and prohibit officials at different hospitals from sharing details of their negotiations. While leaving Sutter intact, the approach would give insurers more negotiating room, particularly in communities with competing providers.
Consolidation in the health care industry is likely here to stay: Two-thirds of hospitals across the nation are part of larger medical systems. "It's very hard to unscramble the egg," said Melnick.
California legislators have attempted to limit the "all or nothing" contracting terms several times, but the legislation has stalled amid opposition from the hospital industry.
Louis Rocco has lived with diabetes for decades but, until he met with a registered dietitian in August, he didn't know eating too much bread was dangerous for him.
"I'm Italian, and I always eat a lot of bread," he said. After two hour-long visits with a dietitian — including a session at his local grocery store in Philadelphia — Rocco, 90, has noticed a difference in his health.
"It's helped bring down my sugar readings," he said of changes in his diet including eating less bread. "I wish I knew I could have had this help years ago."
After getting a referral this summer from his doctor, Rocco learned that Medicare covers personal nutritional counseling for people with diabetes or kidney disease.
The estimated 15 million Medicare enrollees with diabetes or chronic kidney disease are eligible for the benefit, but the federal health insurance program for people 65 and older and some people with disabilities paid for only about 100,000 recipients to get the counseling in 2017, the latest year billing data is available. The data does not include the20 million enrollees in private Medicare Advantage plans.
Health experts say the little-used benefit represents a lost opportunity for beneficiaries to improve their health — and for the program to save money by preventing costly complications from the diseases.
An estimated1 in 4 people 65 and older have diabetes and 1 in 3 have chronic kidney disease. Kidney disease is often a complication of diabetes.
The prevalence of diabetes has risen markedly in the past 20 years and the condition is more common as people age.
Nationwide, there are 100,000 registered dietitians — more than enough to meet demand, said Krista Yoder Latortue, executive director of Family Food in Philadelphia, which employs about 50 dietitians including the one who visited Rocco. Medicare data showed about 3,500 dietitians billed the program for nutritional counseling in 2017.
The problem may be that not enough physicians know about the Medicare benefit. Doctors have to refer patients to a dietitian.
Congress approved the benefit, which began in 2002, after studies found medical nutrition counseling leads to improved health outcomes and fewer complications for older patients. Under the preventive health provisions of the Affordable Care Act, the counseling has been available without out-of-pocket costs to Medicare beneficiaries since 2011.
Medicare pays for three hours of dietary counseling during the first year the benefit is used and two hours in subsequent years. A doctor can appeal to Medicare for additional nutritional therapy if the physician believes it is medically necessary.
Larry Lipman, 70, of Falls Church, Va., said he was shocked to learn he had diabetes earlier this year because he's relatively thin and is an avid cyclist.
When his doctor recommended meeting with a dietitian, he not only said yes but also brought along his wife, who does most of the cooking.
"It was great because I could ask specific questions and get into the nitty-gritty about how I eat, what I eat and when I eat," said Lipman, a retired journalist.
"I've learned I needed to cut down on portion sizes of rice and other things to keep my carbohydrates down," he said. "I'm thinking more about what I eat every time and staying away from Doritos and ice cream."
Doctors shoulder some of the blame for patients not getting dietary counseling by failing to refer them to dietitians.
"It's a lot easier to prescribe a medication than it is to discuss the importance of nutrition and get patients to meet with a registered dietitian," said Dr. Holly Kramer, a Chicago nephrologist and president of the National Kidney Foundation.
"I don't understand how we have this burgeoning obesity and diabetes epidemic and we are not using dietitians in our clinics for all these patients, yet we are paying for all these things that mediate from the disease process such as arthritis, dialysis and amputations," she said.
Jennifer Weis, a registered dietitian in Philadelphia, said the limited hours Medicare covers is frustrating given how difficult it is to change behaviors in older adults.
"It's better than nothing, but in my mind is not sufficient," she said.
Doctors might not be aware of the Medicare option since "it's a challenge to keep up with what is a covered benefit and what is not," said Dr. Michael Munger, chairman of the American Academy of Family Physicians who practices in Overland Park, Kan. He said that many doctors who don't practice with a large health system may not be familiar with dietitians in their community.
For convenience, Munger said, he refers his diabetes patients to a nurse practitioner in his office for nutritional counseling. But only registered dietitians are covered under the Medicare benefit, so his Medicare patients face a copayment for that service.
Nutritional counseling is not the only underused Medicare benefit that can prevent health complications.
Part of the problem, said Yoder Latortue in Philadelphia, is there is a lot of misinformation about whom the public can trust on nutrition advice.
"Everyone eats and everyone has an opinion," Yoder Latortue said.
Lauri Wright, a Jacksonville, Fla., registered dietitian and spokeswoman for the Academy of Nutrition and Dietetics, said the federal Centers for Medicare & Medicaid Services sends out notices to health providers once a year but more information is needed.
About 10,600 registered dietitians have enrolled to treat Medicare patients, a CMS spokeswoman said. She said the agency has been advising health providers about the benefit and promoting it to enrollees on its website and its annual handbook that it sends to beneficiaries.
Still, "I think because only two diseases are covered by Medicare and the rest aren't, it falls off everybody's radar," Wright said.
Hospital prices increased a whopping 42% from 2007 to 2014 for inpatient care and 25% for outpatient care, compared with 18% and 6% for physicians.
Editor's note (9/6/19): HealthLeaders changed the first word of this article's headline from "analysis" to "opinion" to describe its contents more accurately. A version of this article appeared in the opinion section of The New York Times. The opinions expressed in this piece do not constitute the opinions of HealthLeaders or its editorial team.
This article was first published on Thursday, September 5, 2019 in Kaiser Health News.
As voters fume about the high cost of health care, politicians have been targeting two well-deserved villains: pharmaceutical companies, whose prices have risen more than inflation, and insurers, who pay their executives millions in salaries while raising premiums and deductibles.
Although the Democratic presidential candidates have devoted copious airtime to debating health care, many of the country's leading health policy experts have wondered why they have given a total pass to arguably a primary culprit behind runaway medical inflation: America's hospitals.
Data shows that hospitals are by far the biggest cost in our $3.5 trillion health care system, where spending is growing faster than the gross domestic product, inflation and wage growth. Spending on hospitals represents 44% of personal expenses for the privately insured, according to the Rand Corp.
A report this year from researchers at Yale and other universities found that hospital prices increased a whopping 42% from 2007 to 2014 for inpatient care and 25% for outpatient care, compared with 18% and 6% for physicians.
So why have politicians on both the left and right let hospitals off scot-free? Because a web of ties binds politicians to the health care system.
Every senator, virtually every congressman and every mayor of every large city has a powerful hospital system in his or her district. And those hospitals are as politically untouchable as soybean growers in Iowa or oil producers in Texas.
As hospitals and hospital systems have consolidated, they have become the biggest employers in numerous cities and states. They have replaced manufacturing as the hometown industry in a number of Rust Belt cities, including Cleveland and Pittsburgh.
Can Kamala Harris ignore the requests of Sutter Health, Kaiser Permanente, UCLA or any of the big health care systems in California? Can Elizabeth Warren ignore the needs of Partners HealthCare, Boston's behemoth? (Bernie Sanders may be somewhat different on this front because Vermont doesn't have any nationally ranked hospitals.)
Beyond that, hospitals are often beloved by constituents. It's easy to get voters riled up about a drugmaker in Silicon Valley or an insurer in Hartford. It's much riskier to try to direct their venom at the place where their children were born, that employed their parents as nurses, doctors and orderlies, that sponsored local Little League teams, that was associated with their Catholic Church.
And, of course, there's election money. Hospital trade groups, medical centers and their employees are major political donors, contributing to whichever party holds power — and often to the out-of-power party as well. In 2018, PACs associated with the Greater New York Hospital Association, and individuals linked to it, gave $4.5 million to the Democrats' Senate Majority PAC and $1 million to their House Majority PAC. Its chief lobbyist personally gave nearly a quarter of a million dollars to dozens of campaigns last year.
Sen. Sanders has called on his competitors for the Democratic nomination to follow his lead and reject contributions from pharma and insurance. Can any candidate do the same for hospitals? The campaign committees of all 10 candidates participating in the upcoming Democratic debate have plentiful donations linked to the hospital and health care industry, according to Open Secrets.
But the symbiosis between hospitals and politicians operates most insidiously in the subtle fueling of each other's interests. Zack Cooper, a health economist at Yale, and his colleagues looked at this life cycle of influence by analyzing how members of Congress voted for a Medicare provision that allowed hospitals to apply to have their government payments increased. Hospitals in districts of members who voted "yea" got more money than hospitals whose representatives voted "nay," to the collective tune of $100 million. They used that money to hire more staff and increase payroll. They also spent millions lobbying to extend the program.
Members who voted yea, in turn, received a 25% increase in total campaign contributions and a 65% increase in contributions from individuals working in the health care industry in their home states. It was a win-win for both sides.
To defend their high prices, medical centers assert that they couldn't afford to operate on Medicare payments, which are generally lower than what private insurers pay. But the argument isn't convincing.
The cost of a hospital stay in the United States averaged $5,220 a day in 2015 — and could be as high as over $17,000, compared with $765 in Australia. In a Rand study published earlier this year, researchers calculated that hospitals treating patients with private health insurance were paid, overall, 2.4 times the Medicare rates in 2017, and nearly three times the rate for outpatient care. If the plans had paid according to Medicare's formula, their spending would be reduced by over half.
Most economists think hospitals could do just fine with far less than they get today from private insurance.
While on paper many hospitals operate on the thinnest of margins, that is in part a choice, resulting from extravagance.
It would be unseemly for these nonprofit medical centers to make barrels of money. So when their operations generate huge surpluses — as many big medical centers do — they plow the money back into the system. They build another cancer clinic, increase CEO pay, buy the newest scanner (whether it is needed or not) or install spas and Zen gardens.
Some rural hospitals are genuinely struggling. But many American hospitals have been spending capital "like water," said Kevin Schulman a physician-economist at Stanford. The high cost of hospitals today, he said, is often a function of the cost of new infrastructure or poor management decisions. "Medicare is supposed to pay the cost of an efficient hospital," he said. "If they've made bad decisions, why should we keep paying for that?"
If hospitals were paid less via regulation or genuine competition, they would look different, and they'd make different purchasing decisions about technology. But would that matter to medical results? Compared with their European counterparts, some American hospitals resemble seven-star hotels. And yet, on average, the United States doesn't have better outcomes than other wealthy nations. By some measures — such as life expectancy and infant mortality — it scores worse than average.
As attorney general in California, Kamala Harris in 2012 initiated an antitrust investigation into hospitals' high charges. But as a senator and presidential candidate, she has been largely silent on the issue — as have all the other candidates.
As Uwe Reinhardt, the revered Princeton health economist who died in 2017, told me, "If you want to save money, you have to pay less." That means taking on hospital pricing.
So fine, go after drugmakers and insurers. And, for good measure, attack the device makers who profit from huge markups, and the pharmacy benefit managers — the middlemen who negotiate drug prices down for insurers, then keep the difference for themselves.
But with Congress returning to Washington in the coming days and a new Democratic debate less than two weeks away, our elected officials need to address the elephant in the room and tell us how they plan to rein in hospital excesses.
DENVER — A Christian-run health system in Colorado has fired a veteran doctor who went to court to fight for the right of her patient to use the state's medical aid-in-dying law, citing religious doctrine that describes "assisted suicide" as "intrinsically evil."
Centura Health Corp. last week abruptly terminated Dr. Barbara Morris, 65, a geriatrician with 40 years of experience, who had planned to help her patient, Cornelius "Neil" Mahoney, 64, end his life at his home. Mahoney, who has terminal cancer, is eligible to use the state's law, overwhelmingly approved by Colorado voters in 2016.
The growing number of state aid-in-dying provisions are increasingly coming into conflict with the precepts of faith-based hospitals, which oppose the practice on religious grounds.
Morris' dismissal presents an early test of state laws. The Trump administration has moved to broaden the latitude of providers to refuse to participate in medical interventions they object to on religious grounds, though that has previously applied primarily to abortion and contraception.
As hospitals across the country have consolidated, five of the top 10 hospital systems by net patient revenue are associated with the Roman Catholic Church, according to Definitive Health. That includes hospitals that did not previously have any religious affiliation. Meanwhile, there are 10 U.S. jurisdictions where aid-in-dying has been approved and public support for the option is increasing.
The Aug. 26 firing came days after Morris joined with Mahoney in filing a state lawsuit that alleges that Centura's faith-based policy violates the law that allows doctors to prescribe lethal drugs to dying patients who want to end their own lives.
Officials at Centura, a system jointly run by Catholic and Seventh-day Adventist churches, told Morris on Monday that she had defied church doctrines that govern her employment.
"I was shellshocked," Morris said in an exclusive interview with Kaiser Health News. "Because of all the things I expected them to do, that was not in the playbook. Because it seemed so obvious that they can't do it."
But in legal documents filed Friday that ask to elevate the case to federal court and invoke the First Amendment in defense of their actions, Centura officials said Morris had violated terms of her physician's employment agreement and "encouraged an option that she knew was morally unacceptable to her employer."
For Mahoney, the firing deals yet another setback in his quest to use the law. Mahoney, who in July was given four to 14 months to live, said he watched his mother die a slow, painful death and hopes to avoid that for himself.
"Knowing that I could die at home is huge," said Mahoney, who has lost 30 pounds since April, even as his belly swelled painfully with fluid as a result of the cancer. "This gets dragged out too long."
The Trump administration in May approved a so-called conscience rule that strengthens the rights of hospitals and health workers to refuse to participate in patient care based on religious or moral grounds.
At the same time, more doctors and patients in the country are providing and receiving health care subject to religious restrictions. About 1 in 6 acute care beds nationally is in a hospital that is Catholic-owned or -affiliated, said Lois Uttley, a program director for the consumer advocacy group Community Catalyst.
In Colorado, one-third of the state's hospitals operate under Catholic guidelines.
"Rather than encouraging patient Cornelius Mahoney to receive care consistent with that doctrine or transferring care to other providers, you have encouraged a morally unacceptable option," the letter said.
The directives state that Catholic health care providers "may never condone or participate in euthanasia or assisted suicide in any way." Such acts are described as "intrinsically immoral" and "intrinsically evil" in the document.
"Patients experiencing suffering that cannot be alleviated should be helped to appreciate the Christian understanding of redemptive suffering," the document states.
Centura officials confirmed Thursday that Morris is no longer employed there, adding in a statement that the firm "expects all our caregivers to act in a manner consistent with our Mission and Core Values."
Company officials did not address claims that Centura violated state law but argued that its policy prohibiting doctors from prescribing drugs or otherwise participating in medical aid-in-dying is federally protected.
"We believe the freedom of religion doctrine at the heart of the First Amendment to the U.S. Constitution supports our policies as a Christian health-care ministry," Centura spokeswoman Wendy Forbes said in an email. "We will vigorously defend our Constitutional rights."
Legal experts said that Morris' firing may be rare or even unprecedented, but the argument based on the First Amendment has gained support recently in conservative circles.
"In recent years, the radical right has gotten traction with the argument that religious peoples' constitutional rights are violated if they have to follow the same law as everybody else," said Robert Rivas, a Florida lawyer who serves as general counsel for the Final Exit Network, a nonprofit group that promotes right-to-die causes.
"When you look closely at what they are saying," he said, "it turns out they really want to be empowered to force their religion on others."
Officials with the Archdiocese of Denver said they supported Centura's efforts to uphold church doctrine.
"Asking a Christian hospital to play any role in violating the dignity of human life is asking the Christian hospital to compromise its values and core mission," spokesman Mark Haas said in a statement. "This is not the hospital forcing its beliefs upon others, but rather having outside views forced upon it."
The issue is playing out against growing federal protections for religious views of health care, said Kathryn Tucker, executive director of the End of Life Liberty Project and co-counsel on the Centura lawsuit filed Aug. 21.
The Trump administration conscience rule, which was challenged by two dozen states and cities, including Colorado, has been delayed until Nov. 22.
"What's getting lost here is the patient, and the doctor may hold equally strong ethical and religious views as Centura," Tucker said. "Why should their views be overridden by the views of corporate religious medicine?"
Morris' termination was immediate, according to the letter. She was asked to hand over her badge and her company laptop computer. The action abruptly halted her care of 400 geriatric patients and left Morris worried about their future.
"These are complex, ill patients," Morris said. "We have a pretty big thing in medicine about not abandoning patients, so that's a pretty big issue."
In the lawsuit, Morris joined with Mahoney, a Golden, Colo., nursery manager diagnosed in July with stage 4 metastatic cancer. The pair alleged that Centura's policy prohibiting doctors from prescribing aid-in-dying drugs is broader than state law allows.
Colorado's End of Life Options Act, approved by 65% of voters in 2016, allows hospitals and health systems to opt out of offering aid-in-dying drugs for use on their premises.
In addition, another Colorado law says health care facilities may not "limit or otherwise exercise control" over a physician's medical judgment.
The suit asks a judge to rule that the hospital system may not bar Morris from prescribing the lethal drugs — or penalize her if she does.
Centura officials expressed sadness over Mahoney's illness but said the institution promotes "the sacredness of every human life."
After he received his grim diagnosis, Mahoney asked an oncologist and a social worker at his cancer center to help him access aid-in-dying. Both said no.
"I feel like I got slapped in the face," Mahoney said.
Mahoney was advised to transfer his care to a secular provider, but he said he didn't want to undergo additional tests, costs and travel as he struggled with debilitating symptoms.
Morris said she understood that Centura was religiously affiliated when she was hired but didn't anticipate a problem.
"I didn't think it was going to affect my general family practice," she said. "Until these conversations about medical aid-in-dying, I hadn't felt any interference."
Once the law passed, however, a growing number of patients asked about the option.
"I've had patients as they face devastating illness or the end of life where they say, 'Will you do this for me?'" she said, adding later: "At a certain point, we have to stand up for what's right."
Morris is considering her next steps, including separate legal action against Centura over her termination. Mahoney, who is scheduled for his third round of chemotherapy soon, said he's not sure what to do in the wake of the firing.
Raised Catholic, he said, he rejected that theology long ago.
"I don't believe in church. I don't believe in religion," he said. "I just think they're getting way too much power."
Insurance premiums for Washington's individual market are rising less than 1% on average next year, and regulators credit much of that moderation to homegrown insurance companies.
This article was first published on Friday, August 30, 2019 in Kaiser Health News.
SEATTLE — Although few states have finalized their 2020 health insurance rates yet, preliminary reports suggest that increases in premiums for plans sold on the Affordable Care Act's marketplaces will be moderate again this year.
One analysis of those early state filings, which noted some states appear poised to have lower premiums next year, found that Washington had a lower rate increase than almost half the other states.
Insurance premiums for Washington's individual market are rising less than 1% on average next year, and the state's insurance commissioner, Mike Kreidler, credits much of that moderation to homegrown insurance companies.
"We've had locally grown insurers that dominated the health insurance market for individuals," Kreidler said. These insurers are tied to the local community and must succeed in Washington or in the Pacific Northwest region to stay in business. That motivates them to try harder to meet the needs of their customers, he said.
"Insurers that are local and tied to the community — not from out of state, coming in and out — they were ones that need to stay or they weren't going to be in business," Kreidler said.
Nearly 250,000 people who do not get coverage through their employers or the government buy health insurance in Washington's individual market, most of them shopping on the state's ACA exchange, the Washington Healthplanfinder.
The individual insurance market here features companies that do business only in the Pacific Northwest, such as Asuris Northwest Health and Premera Blue Cross. Both nonprofits have been selling health insurance in the region for many years. Premera and its subsidiary LifeWise Health Plan have taken about 13% of the total health insurance market in Washington, selling to companies and individuals, both inside and outside of the Obamacare marketplace.
"Local plans can really make a difference in stabilizing their state-based marketplace," said Emily Curran, a research fellow at the Center on Health Insurance Reforms at the Georgetown University Health Policy Institute in Washington, D.C. They help fill in geographical market gaps and build better partnerships with local doctors and hospitals, and are more effective at reaching underserved populations.
One key to their success, she said, is their commitment to a local market. They can succeed only if they make the business work locally.
"They have an incentive to make sure the market is stable," she said.
Premera, based in Mountlake Terrace, a Seattle suburb, has been selling insurance in Washington for more than 80 years and is now an independent licensee of the Blue Cross Blue Shield Association. It sells plans in 38 of the state's 39 counties and also operates in Alaska.
Asuris has been in the Washington market since 1933 and became part of Portland, Ore.-based Cambia in 1994. Asuris, which is too small to make the top 10 list of insurers in the state, sells health insurance outside the ACA marketplace. Its products are available in eastern Washington and Oregon as well as northern Idaho.
But the two largest companies in Washington's health insurance market are based elsewhere: Kaiser Foundation Health Plan has seized 19% of the market and UnitedHealth Group controls 14%. Washington's Healthplanfinder has shrunk slightly since 2014, from eight companies to six in 2019, but two new outside companies plan to join the market in 2020. (Kaiser Health News has no ties to Kaiser Permanente or the Kaiser Foundation Health Plan.)
Homegrown insurance companies aren't as prominent in other states, where national companies dominate most markets. But Curran said New York is another example of a state with a base of local insurers.
Companies with a bigger footprint can afford more customer churn in their business. The smaller guys need to hang on to its customers, so they offer a wide variety of insurance options, in gold, silver and bronze tiers, both inside and outside of the state marketplace.
But buying from a local plan sometimes has disadvantages. Some companies' plans limit consumers' ability to get full health coverage in other parts of the nation. While local companies are more likely to have agents and brokers who know their customers and their plan offerings, they also have smaller teams than the big national companies and may not be available on weekends and at night, so they cannot respond as quickly to customers' requests.
While Asuris has considered expanding — to the Seattle market, for example — Brady Cass, its president, said that just doesn't make business sense. "Health insurance is personal and it's very local," he said, adding that companies that find their niche, as Asuris has, can more easily weather marketplace storms.
Asuris also markets itself to local companies. Cass, who is a Washington native and has worked for Asuris for 14 years, mentioned examples such as a concierge program Asuris started for both employers and individuals that is designed to help immigrants from Latin America. His company also sent crisis counselors to a workplace where an employee had died on the job.
Barry Baker, CEO of Baker Construction & Development in Spokane, Wash., said Asuris helped his company find economical options for both the company and its employees.
Baker also likes that Cass is involved in his community; they have served on several nonprofit boards together. "He's super community-minded," Baker said. They share business values, making a profit but also putting their profit back to work right where it was earned, he said.
Said Cass: "We've kept our feet squarely in the market that we have built."
In a career full of twists, turns and high-powered assignments, Thomas Insel may now be embarking on one of his most daunting tasks yet — helping California find its way out of a worrisome mental health care crisis.
This year, he assumed a new role to help Gov. Gavin Newsom revamp mental health care in the state. Newsom called Insel his "mental health czar," though his position is unpaid and Insel says it grants him "no authority." Even so, he is zigzagging across California this summer, visiting mental health facilities to try to understand what works and what doesn't.
Insel's meandering career path began early. A precocious student, he enrolled in a joint B.A.-M.D. program at Boston University at age 15 and then took a one-year hiatus to volunteer in clinics across Asia. He returned to finish his medical degree and later completed a three-year psychiatry residency at the University of California-San Francisco.
As a young scientist at the National Institute of Mental Health in the 1980s, Insel researched the effects of antidepressants, then shifted gears to study the neurobiology of emotional attachment in the prairie vole, a rodent known for monogamous behavior.
His groundbreaking research revealedthat the vole's devotion to a single mate was attributable to higher levels of a protein in its brain. That work — along with earlier research on anxiety in monkeys — led to a job running the Yerkes National Primate Research Center in Atlanta starting in 1994. He returned to NIMH in 2002 as its director and headed the institute, the world's largest funder of mental health research, for the next 13 years.
In 2015, Insel left NIMH to lead mental health initiatives at Verily, Google's life sciences research subsidiary. He jumped ship after a year and a half to join a startup, Mindstrong Health, which hopes to prove that the way people use their smartphones can reveal the state of their mental health — and provide opportunities to intervene. Insel also serves as board chairman of the Steinberg Institute, a Sacramento-based nonprofit focused on California mental health policy.
In May, he took a temporary leave from Mindstrong to work intensively, at Newsom's behest, on a mental health plan for the state. He intends to return to the company early next year and continue advising the governor for "as long as I can be useful."
California Healthline joined Insel on Aug. 19 as he toured Oakland's Trust Clinic, a medical and mental health center serving the city's homeless population. We sat down with him for an interview afterward. His comments have been edited for space and clarity.
Q: How would you describe the state of mental health in California and in the U.S.?
California has all the issues every other state has — incarceration, homelessness, fragmentation. More than half of people with mental illness are not getting care. There is a very shallow workforce, particularly for kids. We don't have inpatient beds where we need them.
I've spent 40 years working in this field. We have seen vast improvement in those 40 years in infectious diseases, cardiovascular care, many areas of medicine, but not behavioral health. Suicides are up about 33% since the turn of the century. Overdose deaths are skyrocketing. People with serious mental illness die about 23 years early — and we're not closing that gap. We've got to come up with better solutions now.
Q: What insights are you gaining as you visit programs around the state?
People managing these programs are heroic in what they're able to do with limited resources and tremendous demands. We have 58 mental health systems because we have 58 counties, and we have a separate system for mild to moderate mental illness. It's very fragmented — including between mental health and substance use. One family might interact with four different providers to get behavioral health care. That's not the system one would design if you're starting with the patient.
Q: How should the system be designed?
The system now is crisis-driven. The biggest transformation will come when we can identify problems and intervene earlier. That's when we get the best outcomes in diabetes, heart disease, cancer. It's equally true in behavioral health. We have to manage crisis better, keep people out of the criminal justice system, provide more continuity of care. But we also have to move upstream and capture people much earlier in their journey. This will require building infrastructure we don't have right now: crisis residential beds, sub-acute beds, places for people to live.
Q: So how do we bring about the needed changes?
California has one advantage few states enjoy. The Mental Health Services Act (MHSA) will provide $2.4 billion this year, including for early intervention, prevention and innovation. We also have [other] funds. Every county is using those funds in the way it sees fit.
The time has come to ask: How can we reduce suicide, overdose deaths and re-hospitalization in California? One approach would be to set goals for these, i.e., reduce suicide by X% in Y years. Housing and incarceration have gotten worse over time. Should the state make a pledge to its citizens to do better in those areas?
Q: Who would ensure such a pledge is honored?
Counties are still ground zero for all this. They're our connection to schools and jails, and places where the mental health crisis is playing out. The question is, can the state do more to help them succeed? One thing I've heard from every county is that the burden for documentation means that 35% to 40% of the time is taken up with paperwork, not providing services. Can we set them loose to do what they want to do?
Q: Can technology play a role in improving mental health?
As much as one might hope there'd be an app for that — it's really complicated. In the months I've focused on creating a mental health plan for California, technology is barely in the conversation. Having said that, I do think in the future using digital tools to connect people to care will be transformative.
Q: The recent mass shootings in El Paso and Dayton, like numerous others before them, were perpetrated by angry, alienated young men. What does this say about our culture and the American psyche?
It's a complicated question. There is an element of untreated mental illness that leads to high risk of violence. That violence is usually self-directed in the form of suicide; occasionally, it's other-directed. We did better, oddly enough, when I started in the field than we're doing today in providing more comprehensive, continuous care. I think we are in a crisis, but it's a crisis of care. So whether the mass shootings are a reflection of that or not — maybe to some extent, but they're a small part of a much bigger issue. We are failing to provide care to people with brain disorders. We need to do better.
An Oklahoma judge has ruled that drugmaker Johnson & Johnson helped ignite the state's opioid crisis by deceptively marketing painkillers and must pay $572 million to the state.
Oklahoma sought $17 billion, blaming Johnson & Johnson's marketing practices for fueling the crisis that has claimed the lives of 6,000 people in the state.
It's the first ruling to hold a pharmaceutical company responsible for one of the worst drug epidemics in American history.
Judge Thad Balkman delivered his decision from the bench after presiding over an eight-week civil trial in the college town of Norman, Okla.
"Defendants caused an opioid crisis that is evidenced by increased rates of addiction, overdose deaths and neonatal abstinence syndrome in Oklahoma," Balkman said in the ruling.
Johnson & Johnson immediately released a statement saying that the company "plans to appeal the opioid judgment in Oklahoma."
Oklahoma Attorney General Mike Hunter's suit alleged that Johnson & Johnson, through its pharmaceutical subsidiary Janssen, helped ignite a public health crisis that has killed thousands of state residents.
Balkman, in the ruling, said the state made its case that Johnson & Johnson contributed to the state's opioid crisis.
"The opioid crisis is an imminent danger and menace to Oklahomans," Balkman said. "The state met its burden," proving the company acted improperly with its "misleading marketing and promotion of opioids."
The case is being closely watched by plaintiffs in other opioid lawsuits, particularly the roughly 2,000 cases pending before a federal judge in Ohio.
Initially, Hunter's lawsuit included Purdue Pharma, the maker of OxyContin. In March, Purdue Pharma settled with the state for $270 million, about $200 million of which will fund an addiction research and treatment center at Oklahoma State University in Tulsa. Soon afterward, Hunter dropped all but one of the civil claims, including fraud, against the two remaining defendants.
Just two days before the trial began, one of those two defendants, Teva Pharmaceuticals, based in Israel, announced an $85 million settlement with the state.
Both companies deny any wrongdoing.
Johnson & Johnson marketed the opioid painkillers Duragesic and Nucynta. Lawyers for the company say that its products were highly regulated by the Food and Drug Administration, among other agencies, and that the state did not provide any evidence showing that the company's sales practices helped fuel the crisis.
This story is part of a reporting partnership that includes NPR, StateImpact Oklahoma and other member stations.
In the heat of the most ferocious battle over drug prices in years, pharmaceutical companies are showering U.S. senators with campaign cash as sweeping legislation heads toward the floor.
In the first six months of this year alone, political action committees run by employees of drug companies and their trade groups have given the 30 senators expected to run for reelection nearly $845,000, the latest update to Kaiser Health News' "Pharma Cash to Congress" databaseshows. That hefty sum stands out with Election Day more than 14 months away.
Lowering drug prices is one of the rare causes that has united Democrats and Republicans, and at least one proposal that would change the way the industry does business could get a vote in Congress this year. One of the most promising and aggressive updates would cap drug prices under Medicare so they do not outpace inflation.
The number of big contributions and the lawmakers receiving them signal the industry is building loyalty as voters push candidates to talk about drug prices in the 2020 elections.
For the drug industry, the stakes are high.
"If the Senate flips" to Democrats, "then PhRMA's probably going to have to double its budget," said Kent Cooper, a former Federal Election Commission official who has tracked political money for decades, referring to the industry's biggest lobbying group, the Pharmaceutical Research and Manufacturers of America.
Most of the biggest donations in the first half of 2019 have gone to Republicans, who control the Senate and tend to be more reluctant to restrict drugmakers. And even those who do not serve on committees that oversee the industry or represent states with significant industry ties have benefited from drugmaker cash this year.
"We support candidates from both political parties who support innovation and patient access to medicines," said PhRMA spokeswoman Holly Campbell.
Several senators facing tough reelection campaigns have raked in tens of thousands of dollars this year, with some collecting much more than the industry has given them in the past decade, if ever.
"If it looks as though somebody is going to have a tough run — maybe a friend, maybe somebody you want to develop a better relationship with — you put some extra money in place," said Steven Billet, a former AT&T lobbyist who teaches PAC management at George Washington University.
Thus far, senators running for reelection have together pulled in over $115,000 more than the 27 senators who were running for reelection in mid-2017.
The biggest single beneficiaries were Sens. Chris Coons, a Democrat from Delaware, and Thom Tillis, a North Carolina Republican, who took in a whopping $103,000 and $102,000 respectively in the first six months of the year. Tillis and Coons, the leaders of a Senate subcommittee on intellectual property, have been working on legislation to overhaul the patent system — perhaps the most powerful tool brand-name drugmakers have to keep prices, and profits, high.
Sen. John Cornyn (R-Texas) has been a vocal critic of the way some drugmakers use patents to extend their monopolies on drugs and block competitors, introducing a bill that would empower the government to sue drugmakers for gaming the system.
Cornyn, who faces a difficult reelection fight, received about $65,500.
Another top recipient was Sen. Cory Gardner of Colorado, who is considered the most vulnerable Republican up for reelection in 2020. John Hickenlooper, the state's former governor who dropped out of the Democratic presidential primary on Aug. 15, has decided to challenge Gardner, further complicating his chances of being reelected.
Despite Gardner's lack of pharma-related committee assignments, he received about $81,000 from drugmaker PACs this year, ranking him among the top 10 recipients of pharma cash in Congress. Another vulnerable Republican incumbent, Sen. Joni Ernst of Iowa, received about $35,500 — a huge bump for a lawmaker who, before this year, had collected about $15,000 total during her first term.
Sen. Gary Peters (D-Mich.) is also considered in danger as he runs for reelection in a state that voted for President Donald Trump in 2016. Like Gardner and Ernst, he does not serve on key committees, nor has he played a high-profile role in this year's pushes on drug prices.
Peters received about $49,500 in campaign contributions from drugmaker PACs in the first half of the year, a personal record since being sworn in in 2015. Last year he received about $10,500 from drugmaker PACs in total.
Congressional leaders, who also help fund the campaigns of party members, are a common target of pharmaceutical industry contributions. And with Republicans controlling what legislation comes up in the Senate, Majority Leader Mitch McConnell, also running for reelection, has seen an uptick in donations: He received more than $85,000 during the first half of the year, a record for him over the course of the past eight years.
Drugmaker PACs typically give to most members of Congress, regardless of party. But with Democrats pushing some of the most aggressive proposals to regulate drugmakers, the industry may stand to lose more ground should Democrats regain control of Congress — and political experts say that is a possibility. Democrats are likely to make drug prices a key campaign issue.
"While it may not be true at this very moment, it may well be true that the Democrats will have enough seats in play to really fight for the majority," said Jennifer Duffy, a senior editor at the nonpartisan Cook Political Report. "I think it's a tossup at this point."
The 19 Senate Republicans running in 2020 collected an average of more than $32,500 each from the pharmaceutical industry, while the 11 Democrats collected an average of nearly $20,500 each.
Sen. Bill Cassidy, a Louisiana Republican who is a gastroenterologist by trade and has been active on health care issues, received about $76,000 from drugmaker PACs in the first half of the year despite the likelihood he will be reelected next year.
Pharmaceutical company PAC contributions are only part of the picture, though. Dollars from individual drug company employees may flow in the same direction, as well as "dark money" spending that often dwarfs what must be disclosed.
"The PAC contribution is a signal to other folks who are associated with the industry," Billet said.
Drug prices have been among Americans' top concerns for years. Large, bipartisan majorities favor policiesto control drug costs, including importing drugs from Canada and government negotiations to lower prices paid by Medicare.
Prescription prices remain far higher in the U.S. than in other wealthy countries. Prices for hospital medicines continue to rise. High-deductible health plans have increased the number of patients who feel the drug-price sting directly before insurance kicks in.
New therapies such as genetically altered immune cells to fight cancer, which can cost $1 million per treatment, threaten to renew the cost spiral.
The House also saw an uptick in donations from drug industry PACs during the first half of the year, with the Republican leader, Rep. Kevin McCarthy of California, and the top Republican on the House Energy and Commerce Committee, Rep. Greg Walden of Oregon, taking in the most. McCarthy received about $89,000, while Walden collected about $86,500.